Back to Search Start Over

New Peak Detection Performance Metrics from the MAM Consortium Interlaboratory Study

Authors :
Irina Perdivara
Ben Niu
Kim F. Haselmann
St John Skilton
Anthony Leone
Gregory O. Staples
Carsten P. Sønksen
Helena Maria Barysz
Andrew Hanneman
Chun Shao
Rebecca Scott
Anders Lund
Carly Daniels
Michael Jahn
Da Ren
Nunzio Sepe
K. Ilker Sen
Zoran Sosic
David Ripley
Jing Zhen
Margo Wilson
Melissa Alvarez
John G Hoogerheide
Xinbi Li
Harini Kaluarachchi
Josh Woods
Wenqin Ni
Albrecht Gruhler
Keith A. Johnson
Arnd Brandenburg
Kristen Nields
Michelle Busch
Douglas D. Richardson
Yan Wang
Ahmet Cansizoglu
Xiaoxiao Li
Greg W Adams
Simon Letarte
Joe Shambaugh
Hua Yuan
Trina Mouchahoir
Tom Robinson
Xiaoshi Wang
Nancy S. Nightlinger
Alexander Julian Veach
Chris Chumsae
Eric Carlson
Dongdong Wang
Sean Shen
Jing Fang
Wei Wu
Stefano Gotta
Justin B. Sperry
Hirsh Nanda
X. Christopher Yu
Sibylle Heidelberger
Bhumit A. Patel
Jihong Wang
Sean McCarthy
Himakshi Patel
Thomas N. Krogh
Hunter Walker
Olga V. Friese
Daniela Tizabi
Yali Lu
Kristin Boggio
Ernest L. Maynard
Rich Rogers
Ying Zhou
Nick DeGraan-Weber
John E. Schiel
Weibin Chen
Jason C. Rouse
Li Tao
Thomas W. Powers
John Kim
Xu Guo
Bo Yan
Gabriella Leo
Ying Zhang
Oleg V. Borisov
Ying Qing Yu
Martha Stapels
Wael Yared
Yan-Hui Liu
Alan Heckert
Sarah Rogstad
Li Zang
Aaron Ammerman
Li Cao
Benjamin J. Place
Richard Ludwig
Anton V. Manuilov
Andrew Mahan
Andrew Dawdy
Yi Wang
Brian Schmidt
Peiran Liu
Source :
Journal of the American Society for Mass Spectrometry. 32:913-928
Publication Year :
2021
Publisher :
American Chemical Society (ACS), 2021.

Abstract

The Multi-Attribute Method (MAM) Consortium was initially formed as a venue to harmonize best practices, share experiences, and generate innovative methodologies to facilitate widespread integration of the MAM platform, which is an emerging ultra-high-performance liquid chromatography-mass spectrometry application. Successful implementation of MAM as a purity-indicating assay requires new peak detection (NPD) of potential process- and/or product-related impurities. The NPD interlaboratory study described herein was carried out by the MAM Consortium to report on the industry-wide performance of NPD using predigested samples of the NISTmAb Reference Material 8671. Results from 28 participating laboratories show that the NPD parameters being utilized across the industry are representative of high-resolution MS performance capabilities. Certain elements of NPD, including common sources of variability in the number of new peaks detected, that are critical to the performance of the purity function of MAM were identified in this study and are reported here as a means to further refine the methodology and accelerate adoption into manufacturer-specific protein therapeutic product life cycles.

Details

ISSN :
18791123 and 10440305
Volume :
32
Database :
OpenAIRE
Journal :
Journal of the American Society for Mass Spectrometry
Accession number :
edsair.doi.dedup.....4baf4a0ab2df01bdb011465e0f168239
Full Text :
https://doi.org/10.1021/jasms.0c00415